Modag Gmbh
Clinical trials sponsored by Modag Gmbh, explained in plain language.
-
New PET tracer aims to spot Parkinson's in the brain
Diagnosis Recruiting nowThis early-phase trial tests a new radioactive tracer called [11C]MODAG-005 that binds to abnormal protein clumps in the brain linked to Parkinson's disease and multiple system atrophy. Nine participants (patients with Parkinson's, MSA, and healthy volunteers) will receive the tr…
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
New PET tracer aims to spot Parkinson's in the brain
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [¹⁸F]MODAG-009 to see if it can safely highlight abnormal protein clumps in the brains of people with Parkinson's disease or multiple system atrophy (MSA). About 13 participants, including healthy volunteers, will recei…
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New imaging agent tested in healthy people
Knowledge-focused Recruiting nowThis study is testing a new radioactive tracer called [18F]MODAG-009 in 6 healthy adults. The goal is to see how the tracer moves through the body and how much radiation exposure it causes. Participants get one injection and then a full-body PET scan. This is an early-phase study…
Phase: EARLY_PHASE1 • Sponsor: MODAG GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC